Search Results - "Araie, Hiroaki"

PB1763: THE CELLULAR UPTAKE OF CPX‐351 BY SCAVENGER RECEPTOR CLASS B TYPE 1‐MEDIATED NONENDOCYTIC PATHWAY IN LEUKEMIA CELLS by Araie, Hiroaki, Hosono, Naoko, Yamauchi, Takahiro

Get full text

Clinical outcomes of gemtuzumab ozogamicin for relapsed acute myeloid leukemia: single-institution experience by Hosono, Naoko, Ookura, Miyuki, Araie, Hiroaki, Morita, Mihoko, Itoh, Kazuhiro, Matsuda, Yasufumi, Yamauchi, Takahiro

“…We retrospectively evaluated the clinical efficacy and toxicity of gemtuzumab ozogamicin (GO) in patients with relapsed acute myeloid leukemia (AML). Nineteen…”
Get full text

MALDI-TOFMS-oriented early definitive therapy improves the optimal use of antibiotics for Enterococcus spp. bloodstream infection by Shimamoto, Yuki, Araie, Hiroaki, Itoh, Kazuhiro, Shigemi, Hiroko, Yamauchi, Takahiro, Iwasaki, Hiromichi

“…Enterococci is one of a major cause of bloodstream infection (BSI). Because of its intrinsic drug-resistant nature, empiric antibiotic treatment tends to be…”
Get full text

Prediction of clinical outcome by controlling nutritional status (CONUT) before allogeneic hematopoietic stem cell transplantation in myeloid malignancies by Araie, Hiroaki, Kawaguchi, Yuka, Okabe, Motohito, Lee, Yoonha, Ohbiki, Marie, Osaki, Masahide, Goto, Miyo, Goto, Tatsunori, Morishita, Takanobu, Ozawa, Yukiyasu, Miyamura, Koichi

“…Malnutrition before allogeneic hematopoietic cell transplantation (allo-HCT) is associated with poor clinical outcomes. Herein, we evaluated the predictive…”
Get full text

3A Comparison between R-THP-COP and R-CHOP Regimens for the Treatment of Diffuse Large B-cell Lymphoma in Old Patients: A Single-institution Analysis by Araie, Hiroaki, Sakamaki, Ippei, Matsuda, Yasufumi, Tai, Katsunori, Ikegaya, Satoshi, Itoh, Kazuhiro, Kishi, Shinji, Oiwa, Kana, Okura, Miyuki, Tasaki, Toshiki, Hosono, Naoko, Ueda, Takanori, Yamauchi, Takahiro

“…Objective We retrospectively compared the clinical efficacy and toxicity of rituximab (R)-THP-COP (pirarubicin, cyclophosphamide, vincristine, and…”
Get full text

Clinical outcomes of gemtuzumab ozogamicin for relapsed acute myeloid leukemia: single-institution experience by Hosono, Naoko, Ookura, Miyuki, Araie, Hiroaki, Morita, Mihoko, Itoh, Kazuhiro, Matsuda, Yasufumi, Yamauchi, Takahiro

Get full text

Cellular uptake of CPX-351 by scavenger receptor class B type 1–mediated nonendocytic pathway by Araie, Hiroaki, Hosono, Naoko, Yamauchi, Takahiro

“…•Protein coronas of leukemic cell lines were analyzed for CPX-351 uptake.•There are two pathways for CPX-351 uptake clathrin-mediated and…”
Get full text

P13-5 Autologous transplantation with thiotepa and busulfan for primary neurolymphomatosis with CNS involvement by Araie, Hiroaki, Negoro, Eiju, Yamauchi, Takahiro

Get full text

Leukemic pulmonary infiltration diagnosed by sputum Giemsa-staining by Osaki, Masahide, Lee, Yoonha, Osamura, Yoko, Ichiki, Tomoe, Okabe, Motohito, Kawaguchi, Yuka, Obiki, Marie, Ito, Ai, Goto, Miyo, Araie, Hiroaki, Goto, Tatsunori, Morishita, Takanobu, Ozawa, Yukiyasu, Ito, Masafumi, Miyamura, Koichi

“…A 54-year-old man with acute myeloid leukemia (AML) underwent allogeneic bone marrow transplantation from a human leukocyte antigen-matched unrelated donor in…”
Get more information

Evaluation of Hematopoiesis and Disease Status in Patients with Hematologic Malignancies Using Whole-Body Bone Marrow Imaging with 18 F-FLT PET/MRI by Araie, Hiroaki, Hosono, Naoko, Tsujikawa, Tetsuya, Okazawa, Hidehiko, Yamauchi, Takahiro

“…Introduction Bone marrow examination is primarily focused on a limited region of the ilium, thereby inadequately assessing systemic hematopoiesis or residual…”
Get full text

Hematopoiesis in the spleen after engraftment in unrelated cord blood transplantation evaluated by 18F-FLT PET imaging by Araie, Hiroaki, Hosono, Naoko, Tsujikawa, Tetsuya, Kiyono, Yasushi, Okazawa, Hidehiko, Yamauchi, Takahiro

“…Cord blood is an important donor source for allogeneic hematopoietic stem cell transplantation (allo-HSCT), with its unique composition and quality of…”
Get full text

Hematopoietic status of the whole-body bone marrow in hypoplastic acute promyelocytic leukemia as evaluated by 18F-FLT PET/MRI by Araie, Hiroaki, Tasaki, Toshiki, Hosono, Naoko, Tsujikawa, Tetsuya, Okazawa, Hidehiko, Yamauchi, Takahiro

Get full text

Poor outcome of allogeneic transplantation for therapy-related acute myeloid leukemia induced by prior chemoradiotherapy by Araie, Hiroaki, Arai, Yasuyuki, Kida, Michiko, Aoki, Jun, Uchida, Naoyuki, Doki, Noriko, Fukuda, Takahiro, Tanaka, Masatsugu, Ozawa, Yukiyasu, Sawa, Masashi, Katayama, Yuta, Matsuo, Yayoi, Onizuka, Makoto, Kanda, Yoshinobu, Kawakita, Toshiro, Kanda, Junya, Atsuta, Yoshiko, Yanada, Masamitsu

“…Therapy-related acute myeloid leukemia (t-AML) is a therapeutic challenge as a late complication of chemotherapy (CHT) and/or radiotherapy (RT) for primary…”
Get full text

Hematopoietic status of the whole-body bone marrow in hypoplastic acute promyelocytic leukemia as evaluated by 18 F-FLT PET/MRI by Araie, Hiroaki, Tasaki, Toshiki, Hosono, Naoko, Tsujikawa, Tetsuya, Okazawa, Hidehiko, Yamauchi, Takahiro

Get full text

The Prediction of Clinical Outcome By Controlling Nutrition Status (CONUT) before Allogeneic Hematopoietic Stem Cell Transplantation in Myeloid Malignancies by Araie, Hiroaki, Ichiki, Tomoe, Okabe, Motohito, Kawaguchi, Yuka, Lee, Yoonha, Ohbiki, Marie, Osaki, Masahide, Goto, Miyo, Sato, Takahiko, Goto, Tatsunori, Morishita, Takanobu, Ozawa, Yukiyasu, Miyamura, Koichi

“…Introduction Malnutrition before allogeneic hematopoietic cell transplantation (allo-HCT) is known to associate with poor clinical outcome. Although various…”
Get full text

The stability of initial tacrolimus concentration following allogeneic hematopoietic stem cell transplantation reduces the risk of acute GVHD by Okabe, Motohito, Morishita, Takanobu, Ichiki, Tomoe, Kawaguchi, Yuka, Lee, Yoonha, Ohbiki, Marie, Goto, Miyo, Osaki, Masahide, Araie, Hiroaki, Goto, Tatsunori, Ozawa, Yukiyasu, Miyamura, Koichi

“…Background Early tacrolimus (TAC) concentrations correlate with the risk of acute graft‐versus‐host disease (aGVHD); however, whether the variability of early…”
Get full text

Higher Peak Tacrolimus Concentrations after Allogeneic Hematopoietic Stem Cell Transplantation Increase the Risk of Endothelial Cell Damage Complications by Morishita, Takanobu, Okabe, Motohito, Kawaguchi, Yuuka, Lee, Yoonha, Ohbiki, Marie, Osaki, Masahide, Goto, Miyo, Araie, Hiroaki, Sato, Takahiko, Goto, Tatsunori, Ozawa, Yukiyasu, Miyamura, Koichi

“…•We retrospectively evaluated 295 patients who received allo-HSCT from 2009 to 2016.•We evaluated the impact of tacrolimus blood levels on the occurrence of…”
Get full text

Myeloid Leukemia with Myelodysplasia-Related Changes Was Not a Prognostic Factor Under Allogenic Hematopoietic Stem Cell Transplantation by Lee, Yoonha, Ichiki, Tomoe, Okabe, Motohito, Kawaguchi, Yuka, Ohbiki, Marie, Osaki, Masahide, Goto, Miyo, Sato, Takahiko, Araie, Hiroaki, Goto, Tatsunori, Morishita, Takanobu, Ozawa, Yukiyasu, Miyamura, Koichi

“…Acute myeloid leukemia with myelodysplasia-related changes (AML-MRC) is briefly defined as an AML which have multilineage dysplasia (MLD), a history of…”
Get full text